Cargando…

Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era

BACKGROUND: Osteoporosis is a well-known extra articular manifestation in rheumatoid arthritis (RA). Biologic disease modifying anti rheumatic drugs (DMARDs) has been shown to be superior to synthetic DMARDs to reduce bone destruction including generalized bone loss in RA. Our aim was to study short...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haugeberg, Glenn, Helgetveit, Knut Bjørn, Førre, Øystein, Garen, Torhild, Sommerseth, Hege, Prøven, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161846/ https://www.ncbi.nlm.nih.gov/pubmed/25182527 http://dx.doi.org/10.1186/1471-2474-15-289

Ejemplares similares

No deterioration in health-related quality of life in patients with axial spondyloarthritis followed for 5 years in ordinary outpatient clinics in the biological treatment era
por: Rohde, Gudrun, et al.
Publicado: (2019)

Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss
por: Hoff, Mari, et al.
Publicado: (2007)

Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway
por: Haugeberg, Glenn, et al.
Publicado: (2015)

Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
por: Hoff, Mari, et al.
Publicado: (2011)

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
por: Deyab, Gia, et al.
Publicado: (2021)

The relationship between demographic- and disease-related variables and health-related quality of life in patients with axial spondyloarthritis
por: Rohde, Gudrun, et al.
Publicado: (2017)

Bacteria in the Adventitia of Cardiovascular Disease Patients with and without Rheumatoid Arthritis
por: Curran, Samuel A., et al.
Publicado: (2014)

Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era
por: Haugeberg, Glenn, et al.
Publicado: (2020)

A hospital based registry of juvenile idiopathic arthritis in Norway
por: Ingebrigtsen, Trude M, et al.
Publicado: (2014)

Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010–2019)
por: Brkic, Alen, et al.
Publicado: (2023)

Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis
por: Lindner, Ewald, et al.
Publicado: (2007)

Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study
por: Hoff, M, et al.
Publicado: (2008)

Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab
por: Łosińska, Katarzyna, et al.
Publicado: (2023)

Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial
por: Kåss, Anita, et al.
Publicado: (2015)

The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis
por: Mjaavatten, Maria D, et al.
Publicado: (2010)

A Comparison of Disease Burden in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis
por: Michelsen, Brigitte, et al.
Publicado: (2015)

Long-term drug effectiveness and survival for reference rituximab in rheumatoid arthritis patients in an ordinary outpatient clinic
por: Łosińska, Katarzyna, et al.
Publicado: (2022)

Decentralizing healthcare in Norway to improve patient-centered outpatient clinic management of rheumatoid arthritis – a conceptual model
por: Brkic, Alen, et al.
Publicado: (2021)

Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway
por: Haugeberg, Glenn, et al.
Publicado: (2018)

Mannose-binding lectin deficiency is associated with early onset of polyarticular juvenile rheumatoid arthritis: a cohort study
por: Dolman, Koert M, et al.
Publicado: (2008)

Interstitial Lung Disease in Rheumatoid Arthritis in the Era of Biologics
por: Picchianti Diamanti, A., et al.
Publicado: (2011)

Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis
por: Brkic, Alen, et al.
Publicado: (2022)

Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study
por: Bøyesen, Pernille, et al.
Publicado: (2009)

A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis
por: Skinningsrud, Beate, et al.
Publicado: (2010)

Nutrition and Rheumatoid Arthritis in the ‘Omics’ Era
por: Cassotta, Manuela, et al.
Publicado: (2021)

Rheumatoid Arthritis in the Era of COVID-19 Pandemic
por: Abbas, Ahmed M., et al.
Publicado: (2020)

Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort
por: Mjaavatten, Maria D, et al.
Publicado: (2009)

Balancing benefits and risks in the era of biologics
por: Adami, Giovanni, et al.
Publicado: (2019)

Rheumatoid arthritis: travelling biological era a Romanian X–ray population
por: Mogosan, C, et al.
Publicado: (2009)

Pathomechanisms of bone loss in rheumatoid arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2022)

Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates
por: Haugeberg, Glenn, et al.
Publicado: (2020)

Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study
por: Kåss, AS, et al.
Publicado: (2014)

Serum levels of osteoprotegerin and receptor activator of nuclear factor -κB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study
por: Lien, Gunhild, et al.
Publicado: (2010)

Chemokine blockade: a new era in the treatment of rheumatoid arthritis?
por: Haringman, Jasper J, et al.
Publicado: (2004)

Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Inflammatory cells and bone loss in rheumatoid arthritis
por: Haynes, David R
Publicado: (2007)

Less periprosthetic bone loss following the anterolateral approach to the hip compared with the direct lateral approach: A subgroup analysis from a randomized trial in patients with a femoral neck fracture
por: Ugland, Terje O, et al.
Publicado: (2018)

EULAR Task Force Recommendations on Annual Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis: An Audit of the Success of Implementation in a Rheumatology Outpatient Clinic
por: Ikdahl, Eirik, et al.
Publicado: (2015)

Role of DNA dioxygenase Ten-Eleven translocation 3 (TET3) in rheumatoid arthritis progression
por: Kawabe, Akio, et al.
Publicado: (2022)

Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis
por: Haugeberg, Glenn, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gdu8gd2pb1tuubs2uq1qa7ja7k